Intraperitoneal Once-Daily Dose of Cefazolin and Gentamicin for Treating Capd Peritonitis

Bailie G.R. , Haqqie S.S. , Eisele G. , Gorman T. , Low C.L. Effectiveness of once-weekly vancomycin and oncedaily gentamicin, intraperitoneally, for CAPD peritonitis. Perit Dial Int 1995; 15: 269–71.

Lye W.C. , Wong P.L. , vander Straaten J.C. , Leong S.O. , Lee E.J.C. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1995; 11: 179–81.

Weber J. , Staerz E. , Mettang T. , Machleidt C. , Kuhlmann U. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin. Perit Dial Int 1989; 9: 191–5.

Vas S.I. Treatment of peritonitis. Perit Dial Int 1994; 14(Suppl 3): S49–55.

Klastersky J. , van der Auwera P. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of

Bunke M. , Brier M.E. , Golper T.A. Culture-negative CAPD peritonitis: the network 9 study. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1994; 10: 174–8.

Gendeh B.S. , Said H. , Gibb A.G. , Aziz N.S. , Kong N. , Zahir Z.M. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis. JLaryngol Otol 1993; 107: 681–5.

Bunke C.M. , Aronoff G.R. , Brier M.E. , Sloan R.S. , Luft F.C. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 33: 66–72.

Somani P. , Shapiro R.S. , Stockard H. , Higgins J.T. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1982; 32: 113–21.